Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by TheMadMonkon Nov 07, 2023 5:11pm
254 Views
Post# 35722386

AC/DC Albums for 200 Alex

AC/DC Albums for 200 AlexThis 1980's Hard Rock album was the seventh studio album from the Australian music group AC/DC.  What is Back in Black?  To quote the great British rocker Brian Johnson "Well, I'm back in black, Yes, I'm back in black".  I have to admit, ATE is going up much faster than I expected.  We still have PK/PD results, Earnings Report, Corporate Update, and the verdict in the Nuance arbitration case all expected in the next four weeks or so.  I find it funny how many people were trashing this stock a few weeks ago at 46 cents and are now lining up to buy it at $1.05  Market psychology, who can figure it out?  The rest of 2023 should be very interesting.
<< Previous
Bullboard Posts
Next >>